The discussion will be centered on our comprehensive experiences in handling oncolytic viruses. Specifically, we will focus on the intricacies involved in the production of egg-based vaccines, followed by an illuminating presentation of data related to adeno-associated virus (AAV).

Join us to learn about the latest innovations in ddPCR and how they can help you bring new and safe gene therapies to market faster!

A deep dive into the dangers of fentanyl entering the US supply chain – and the importance of the Drug Supply Chain Security Act

How the European Commission has struck deals to secure manufacturing capacity for future emergencies.

Exploring the ins and outs of a recent UK-based collaboration between two prominent advanced medicine players

What can the pharma industry do about the glass ceiling in women’s careers?

Scientists celebrate a new era of genetic medicine but what do we do about the costs?

The use of multimodal chromatography is increasing in biopharma purification processes. Here’s why.

Researchers develop a new approach to mapping the individual heterogeneity of brain changes in mental disorders